Archives of Pharmacal Research

, Volume 15, Issue 2, pp 162–168 | Cite as

Preparation andIn vitro release characteristics of hydrophilic albumin microspheres containing methotrexate and methotrexate-human serum albumin conjugates

  • Sung-Joo Hwang
  • Myung Gull Lee
  • Chong-Kook Kim
Original Articles


Release characteristics of five different types of hydrophilic albumin microspheres (HAM) containing different ratios of methotrexate-albumin (MTX-HSA) conjugates to free MTX; 1∶0 (HAMC), 3∶1 (HAMC3F), 1∶1 (HAMCF), 1∶3 (HAMCF3) and 0∶1 (HAMF) were investigated in the absence or presence of protease using dissolution tester. In all the HAMs studied except HAMC, the MTX was released bi-exponentially in the absence of protease; an initial fast release period up to approximately 6 h, and thereafter the release rate was very much slower. The fast release of MTX from the HAMs (such as HAMC3F, HAMCF, HAMCF3 and HAMF) at the initial phase is probably due to the release of “physically associated” MTX on the surface and/or entrapped in the near inner surface of HAMs and the slow release at the second phase is due to the release of entrapped free MTX from the core of the HAMs. The initial rate constants were 7.2, 8.7, 8.5 and 5.9 times greater than the second rate constants for HAMF, HAMCF3, HAMCF and HAMC3F, respectively. MTX release from HAMC was very slow and mono-phasic. It was at most 2.2% of the total entrapped amount by 24 h. The protease accelerated the release of MTX from the HAMs. The percentages of MTX released from HAMs up to 24 h were 100, 89.0, 75.0, 66.0 and 61.0% for HAMF, HAMCF3, HAMCF, HAMC3F and HAMC, respectively in the presence of protease and the corresponding values in the absence of protease were 30.2, 19.0, 10.0, 6.5 and 2.2%, respectively.In vitro release of MTX in the presence of protease varied according to the ratios of MTX-HSA conjugates to MTX; the data set from HAMF, HAMCF3 and HAMCF fits better to monophasic first-order profile more adequately than to zero-order profile, that of HAMC3 F to mono-phasic zero-order, and that of HAMC to bi-phasic zero-order. Above results suggested that zero-order release rate can be achieved by adjusting the ratio of MTX-HSA conjugates to MTX in the preparation of HAMs such as HAMC3F.


Hydrophilic albumin microspheres methotrexate methotrexate-human serum albumin conjugates in vitro drug release drug release by protease zero-order release 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature Cited

  1. 1.
    Kramer, P. A.: Albumin microspheres as vehicles for achieving specificity in drug delivery.J. Pharm. Sci.,63, 1646–1647 (1976).CrossRefGoogle Scholar
  2. 2.
    Yang, J.-S.:Development of liver-targeting adriamycin delivery system using human serum albumin microspheres, Ph.D Thesis, Seoul National University, Seoul, Korea (1986).Google Scholar
  3. 3.
    Willmot, N., Chen, Y., Goldberg, J., Mcardle, C. and Florence, A. T.: Biodegradation rate of embolized protein microspheres in lung, liver and kidney of rats.J. Pharm. Pharmcol.,41, 433–438 (1989).Google Scholar
  4. 4.
    Kim, C.-K., Jeong, E. J., Yang, J. S. and Kim, S. H.: Development of specific organ targeting drug delievery system. I. Physico-pharmaceutical characteristics of thermally denatured albumin microspheres containing cytarabine.Arch. Pharm. Res.,8 159–168 (1985).CrossRefGoogle Scholar
  5. 5.
    Kim, C.-K. and Lee, J. K.: Development of specific organ targeting drug delivery system. II. Physico-pharmaceutical study on the cross-linked albumin microspheres containing cytarabine.Arch. Pharm. Res.,9, 39–43 (1986).CrossRefGoogle Scholar
  6. 6.
    Kim, C.-K., Hwang, S.-J. and Yang, J.-S.: Development of specific organ-targeting drug delivery system. III.In vitro study on liver-targeting adriamycin delivery system using human serum albumin microspheres.J. Kor. Pharm. Sci. 19, 195–202 (1989).Google Scholar
  7. 7.
    Kim, C.-K. and Oh, Y.-K.: Development of hydrophilic human serum albumin microspheres using a drug-albumin conjugates.Int. J. Pharm. 47, 163–169 (1988).CrossRefGoogle Scholar
  8. 8.
    Gupta, P. K. and Hung, C. T.: Albumin microspheres. V. Evaluation of parameters controlling the efficacy of magnetic microspheres in the targeted delivery of adriamycin in rats.Int. J. Pharm. 59, 57–67 (1990).CrossRefGoogle Scholar
  9. 9.
    Chu, B. C. F. and Whiteley, J. M.: High molecular weight derivatives of methotrexate as chemotherapeutic agents.Mol. Pharmacol. 13, 80–88 (1977).PubMedGoogle Scholar
  10. 10.
    Chu, B. C. F. and Whiteley, J. M.: Control of solid tumor metastases with a high molecular-weight derivatives of methotrexate.J. Natl. Cancer Inst.,62, 79–81 (1979).PubMedGoogle Scholar
  11. 11.
    Halbert, G. W., Florence, A. T. and Stuart, J. F. B.: Characterization ofin vitro drug release and biological activity of methorexate-bovine serum albumin conjugates.J. Pharm. Pharmacol.,39, 871–876 (1987).PubMedGoogle Scholar
  12. 12.
    Kim, C.-K., Lee, M. G., Park, M. K., Lee, H.-J. and Kang, H. J.:In vitro drug release characteristics of methotrexate-human serum conjugates.Arch. Pharm. Res.,12, 186–190 (1989).CrossRefGoogle Scholar
  13. 13.
    Yoon, E. J., Chang, H. W., Lee, M. G., Lee, H.-J., Park, M. K. and Kim, C. K.: Pharmacokinetics of methotrexate after intravenous infusion of methotrexate-rabbit serum albumin conjugate to rabbits.Int. J. Pharm.,67, 177–184 (1991).CrossRefGoogle Scholar
  14. 14.
    Longo, W. E. and Goldberg, E. P.: Hydrophilic albumin microspheres.Metholds Enzymol.,112, 3–18 (1985).CrossRefGoogle Scholar
  15. 15.
    Torrado, J. J., Illum, L. and Davis, S. S.: Particle size and size distribution of albumin microspheres produced by heat and chemical stabilization.Int. J. Pharm.,51, 85–90 (1989).CrossRefGoogle Scholar
  16. 16.
    Gupta, P. K, Hung, C. T. and Perrier, D. G.: Albumin microspheres. I. Release characteristics of adriamycin.Int. J. Pharm. 33, 137–146 (1986).CrossRefGoogle Scholar
  17. 17.
    Paxton J. W.: Protein binding of methothexate in sera from normal human being: Effect of drug concentration, pH, temperature and storage.J. Pharmacol. Methods,5, 203–213 (1981).PubMedCrossRefGoogle Scholar
  18. 18.
    Sheu, M. T., Moustafa, M. A. and Sokoloski, T. D.: Entrapment of bioactive compounds within native albumin beads. II. Effects of rate and extent of cross-linking on microbeads properties.J. Parent. Sci. Technol.,40, 253–258 (1986).Google Scholar

Copyright information

© The Pharmaceutical Society of Korea 1992

Authors and Affiliations

  • Sung-Joo Hwang
    • 2
  • Myung Gull Lee
    • 1
  • Chong-Kook Kim
    • 1
  1. 1.College of PharmacySeoul National UniversitySeoulKorea
  2. 2.College of PharmacyChungnam National UniversityTaejeonKorea

Personalised recommendations